Guillain-Barré syndrome.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001341:Autonomic Nervous System / Q000503:physiopathology; D003711:Demyelinating Diseases / Q000276:immunology; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009431:Neural Conduction; D010956:Plasmapheresis; D011129:Polyradiculoneuropathy / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D014481:United States
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents